Mitchell Charles F, Pearce Shane
Urology, Elson S. Floyd College of Medicine, Washington State University, Spokane, USA.
Urology, Spokane Urology, Spokane, USA.
Cureus. 2022 Feb 14;14(2):e22210. doi: 10.7759/cureus.22210. eCollection 2022 Feb.
Adenocarcinoma of the rete testis is an extremely rare and aggressive tumor that carries a poor prognosis. Successful long-term treatment for such tumors remains elusive as more cases are discovered worldwide. Treatment typically involves radical orchiectomy, retroperitoneal pelvic lymph node dissection, adjuvant chemotherapy, and/or continued surveillance. Here we describe the case of a 42-year-old male with a history of low testosterone who presented with a localized adenocarcinoma of the left rete testis. He was treated with radical orchiectomy and continued surveillance alone due to a lack of evidence of metastasis on follow-up imaging. History, prognosis, diagnostics, and treatment guidelines, as well as the most significant recent cases since the last rete testis adenocarcinoma literature meta-analysis, are discussed.
睾丸网腺癌是一种极其罕见且侵袭性强的肿瘤，预后较差。随着全球发现的病例增多，针对此类肿瘤的成功长期治疗方法仍然难以捉摸。治疗通常包括根治性睾丸切除术、腹膜后盆腔淋巴结清扫术、辅助化疗和/或持续监测。在此，我们描述了一名42岁男性的病例，该男性有睾酮水平低的病史，表现为左侧睾丸网局限性腺癌。由于随访影像学检查未发现转移证据，他接受了根治性睾丸切除术并仅进行持续监测。本文讨论了该疾病的病史、预后、诊断和治疗指南，以及自上次睾丸网腺癌文献荟萃分析以来最重要的近期病例。
